Close menu




August 2nd, 2022 | 10:57 CEST

Defence Therapeutics VP Research + Development Dr. Moutih Rafei on the next generation oncology-targeting therapies

  • Expert
  • Biotech
  • Cancer
  • DefenceTherapeutics
Photo credits: pixabay.com

The publicly traded biotechnology company called Defence Therapeutics is developing new vaccines and ADC products on its own proprietary platform. The Accum technology, which enables precise delivery of vaccine antigens or ADCs in their intact form to target cells, forms the basis of Defence Therapeutics' platform. As a result, catastrophic illnesses like cancer and infectious diseases can be combated with greater efficacy and potency.

time to read: 1 minutes | Author: Mario Hose
ISIN: DEFENCE THERAPEUTICS INC | CA24463V1013

Table of contents:


    Cancer is one of the most common causes of death and those affected often have a long journey of suffering. What progress can Defence Therapeutics show in the field of fighting the disease?

    'Cancer is a multifactorial disease caused by mutations accumulated through years. Therefore, targeting cancer through a specific pathway may not lead to the hoped-for outcome.

    Defence is working on the development of the next generation oncology-targeting therapies. Most of its arsenal is based on the use of the Accum technology, which consists of empowering biomedicine's accumulation into target cells via endosomal escape.

    As such, the company has developed antibody-drug conjugates, anti-cancer small molecules and protein- or cell-based anti-cancer vaccine formulations. Multiple Phase I trials using some of these products are expected to start in Q1/Q2 of 2023.'

    Dr. Moutih Rafei, VP Research & Development, Defence Therapeutics Inc.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Mario Hose on August 1st, 2022 | 06:00 CEST

    Desert Gold Ventures CEO Jared Scharf on gold as a hedge against inflation

    • Expert
    • DesertGold
    • Gold

    As the European Central Bank raised its interest rate by 50 basis points on July 21 in line with the U.S. Fed and the Bank of England, the price of gold in the London Bullion Market Association fell to USD 1,700 per ounce. Recession danger is rising as more rate increases are anticipated. Changing consumer and equity market conditions are reflected in declining physical and exchange-traded fund demand for gold. Desert Gold Ventures CEO Jared Scharf explains us his view.

    Read

    Commented by Mario Hose on July 28th, 2022 | 05:30 CEST

    Almonty Industries CEO Lewis Black on the global dependence on China

    • Expert
    • Tungsten
    • Almonty
    • Mining

    Lewis Black is the CEO of Almonty Industries and has over 15 years of experience in the mining industry. The company is specialized in acquiring operations and assets in tungsten markets. Tungsten is one of the critical raw materials and with this in mind, Almonty's work is of importance to many different processing industries around the globe. In the current tense situation in connection with supply chain issues and sanctions as well as environmental protection requirements, the company is increasingly coming into focus.

    Read

    Commented by Mario Hose on July 26th, 2022 | 09:54 CEST

    Enapter CEO Sebastian-Justus Schmidt exclusively on the offer in the current energy situation in Germany

    • Expert
    • Hydrogen
    • Enapter

    Sebastian-Justus Schmidt founded Enapter to build green energy systems where there is a financial advantage over fossil fuel use in the medium term. He is sure that future-oriented companies need application-oriented, effective research and development with intensive software support as a foundation.

    Read